Psychosomatische Aspekte von chronischen muskuloskelettalen Schmerzen

Die Therapie chronischer muskuloskelettaler Schmerzen gelingt nur durch die Kenntnis der zugrunde liegenden psychosomatischen (biopsychosozialen) Aspekte. Wiederkehrende Muster sind Schmerzvermeidung durch Bewegungsvermeidung und instabile Bindungsstile, die in Teufelskreise führen und diese aufrechterhalten. Dieser Artikel zeigt, welche Verhaltens- und Beziehungsmuster chronische Schmerzen beeinflussen und wie man sie erfolgreich behandeln kann.

Schlüsselwörter

Chronische Schmerzen - Schmerzvermeidungsverhalten - somatoforme Schmerzstörung - multimodale Schmerztherapie - Selbstwirksamkeit

• Literatur

• 1 Treede RD, Rief W, Barke A. et al. A classification of chronic pain for ICD-11. Pain 2015; 156: 1003-1007
• 2 von der Lippe E, Krause L, Porst M. et al. Prevalence of back and neck pain in Germany. Results from the BURDEN 2020 Burden of Disease Study. J Health Monit 2021; 6: 2-14
• 3 Urwin M, Symmons D, Allison T. et al. Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann Rheum Dis 1998; 57: 649-655
• 4 Nguyen US, Zhang Y, Zhu Y. et al. Increasing prevalence of knee pain and symptomatic knee osteoarthritis: survey and cohort data. Ann Intern Med 2011; 155: 725-732
• 5 Hauser W, Marschall U, LʼHoest H. et al. Administrative prevalence, treatment and costs of somatoform pain disorder. Analysis of data of the BARMER GEK for the years 2008–2010. Schmerz 2013; 27: 380-386
• 6 AWMF. Nationale Versorgungsleitlinie Kreuzschmerz 2017. Accessed October 24, 2023 at: https://www.leitlinien.de/themen/kreuzschmerz
• 7 Hasenbring M, Hallner D, Klasen B. Psychological mechanisms in the transition from acute to chronic pain: over- or underrated?. Schmerz 2001; 15: 442-447
• 8 Barke A, Korwisi B, Jakob R. et al. Classification of chronic pain for the International Classification of Diseases (ICD-11): results of the 2017 international World Health Organization field testing. Pain 2022; 163: e310-e318
• 9 Wippert PM, Puschmann AK, Arampatzis A. et al. Diagnosis of psychosocial risk factors in prevention of low back pain in athletes (MiSpEx). BMJ Open Sport Exerc Med 2017; 3: e000295
• 10 Fink P. Surgery and medical treatment in persistent somatizing patients. J Psychosom Res 1992; 36: 439-447
• 11 Kouyanou K, Pither CE, Rabe-Hesketh S. et al. A comparative study of iatrogenesis, medication abuse, and psychiatric morbidity in chronic pain patients with and without medically explained symptoms. Pain 1998; 76: 417-426
• 12 Waddell G, Newton M, Henderson I. et al. A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain 1993; 52: 157-168
• 13 Frey P-E, Schiltenwolf M. Chronic pain and exercise. Dtsch Z Sportmed 2022; 73: 98-105
• 14 Diehl K, Mayer J, Thiel A. et al. Playing hurt: dealing with joint pain in adolescent elite athletes. Schmerz 2019; 33: 49-56
• 15 Tesarz J, Schuster AK, Hartmann M. et al. Pain perception in athletes compared to normally active controls: a systematic review with meta-analysis. Pain 2012; 153: 1253-1262
• 16 Pfeifer AC, Ehrenthal JC, Neubauer E. et al. Impact of attachment behavior on chronic and somatoform pain. Schmerz 2016; 30: 444-456
• 17 Bowlby J. Developmental psychiatry comes of age. Am J Psychiatry 1988; 145: 1-10
• 18 Pfeifer AC, Penedo JMG, Ehrenthal JC. et al. Impact of attachment behavior on the treatment process of chronic pain patients. J Pain Res 2018; 11: 2653-2662
• 19 AWMF. Funktionelle Körperbeschwerden. Registernummer 051–001. 2018
• 20 Ferraro MC, Bagg MK, Wewege MA. et al. Efficacy, acceptability, and safety of antidepressants for low back pain: a systematic review and meta-analysis. Syst Rev 2021; 10: 62
• 21 Birkinshaw H, Friedrich CM, Cole P. et al. Antidepressants for pain management in adults with chronic pain: a network meta-analysis. Cochrane Database Syst Rev 2023; 5: CD014682
• 22 Kent P, Haines T, OʼSullivan P. et al. Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial. Lancet 2023; 401: 1866-1877
• 23 Costa Lda C, Maher CG, McAuley JH. et al. Self-efficacy is more important than fear of movement in mediating the relationship between pain and disability in chronic low back pain. Eur J Pain 2011; 15: 213-219
• 24 Schiltenwolf M, Beckmann N, Gaidzik P. Expert Opinions in Court: Liability of the Expert. Z Orthop Unfall 2017; 155: 727-731
• 25 Kasper LA, Pfeifer AC, Volkert J. et al. Mentalizing the pain-Implementation of a mentalization-based manual for the therapeutic support of pain patients. Schmerz 2023;
• 26 Schiltenwolf M, Buchner M, Heindl B. et al. Comparison of a biopsychosocial therapy (BT) with a conventional biomedical therapy (MT) of subacute low back pain in the first episode of sick leave: a randomized controlled trial. Eur Spine J 2006; 15: 1083-1092
• 27 Waterschoot FPC, Dijkstra PU, Hollak N. et al. Dose or content? Effectiveness of pain rehabilitation programs for patients with chronic low back pain: a systematic review. Pain 2014; 155: 179-189
• 28 Kamper SJ, Apeldoorn AT, Chiarotto A. et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ 2015; 350: h444